Revisiting definition and classification of cardiomyopathies in the era of molecular medicine

European Heart Journal

Volumn 29, Issue 2, 2008, Pages 144-146

  Thiene, Gaetano ^a   Corrado, Domenico ^a   Basso, Cristina ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TROPOMYOSIN; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN BETA; TROPONIN I; TROPONIN T;

CARDIOMYOPATHY; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CHANNELOPATHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EDITORIAL; ELECTROCARDIOGRAM; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IN SITU HYBRIDIZATION; MEDICAL SOCIETY; MEDICINE; MOLECULAR BIOLOGY; MYOCARDIAL DISEASE; PATHOGENESIS; PERICARDIAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION; WORLD HEALTH ORGANIZATION;

CARDIOLOGY; CARDIOMYOPATHIES; HUMANS; MOLECULAR BIOLOGY;

EID: 38349157089     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm585     Document Type: Editorial

References (15)

1. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 1980;44:672-673.
2. Thiene G, Basso C, Calabrese F, Angelini A, Valente M. Twenty years of progress and beckoning frontiers in cardiovascular pathology: cardiomyopathies. Cardiovasc Pathol 2005;14:165-169.
3. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996;93:841-842.
4. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Khul U, Maisch B, McKenna WJ, Monserrat L, Oankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008;29:270-276. First published on October 4, 2007, doi:10.1093/eurheartj/ehm342.
5. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB; American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; Council on Epidemiology and Prevention. Contemporary definitions and classification of the cardiomyopathies. An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups, and council on epidemiology and prevention. Circulation 2006;113:1807-1816.
6. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988;318:129-133.
7. Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau JL, Malergue C, Grosgogeat Y. Right ventricular dysplasia: a report of 24 adult cases. Circulation 1982;65:384-398.
8. Angelini A, Calzolari V, Thiene G, Boffa GM, Valente M, Daliento L, Basso C, Calabrese F, Razzolini R, Livi U, Chioin R. Morphologic spectrum of primary restrictive cardiomyopathy. Am J Cardiol 1997;80:1046-1050.
9. Calabrese F, Thiene G. Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects. Cardiovasc Res 2003;60:11-25.
10. Bowles NE, Bowles KR, Towbin JA. The 'final common pathway' hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy. Herz 2000;25:168-175.
11. Thiene G, Corrado D, Basso C. Cardiomyopathies: is it time for a molecular classification? Eur Heart J 2004;25:1772-1775.
12. Badorff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, Rhoads RE, Knowlton KU. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 1999;5:320-326.
13. Ashrafian H, Watkins H. Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications cardiomyopathies: therapeutics based on molecular phenotype. J Am Coll Cardiol. 2007;49:1251-1264.
14. Marcus FI, Nava A, Thiene G, eds. Arrhythmogenic RV Cardiomyopathy/Dysplasia - Recent Advances. Milano: Springer; 2007.
15. Lehnart SE, Ackerman MJ, Benson DW Jr, Brugada R, Clancy CE, Donahue JK, George AL Jr, Grant AO, Groft SC, January CT, Lathrop DA, Lederer WJ, Makielski JC, Mohler PJ, Moss A, Nerbonne JM, Olson TM, Przywara DA, Towbin JA, Wang LH, Marks AR. Inherited Arrhythmias: A National Heart, Lung, and Blood Institute and Office of Rare Diseases Workshop Consensus Report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. Circulation 2007;116:2325-2345.